# Response Prediction in EBV-HLH Using Metabonomics Analysis

> **NCT05677178** · — · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytoses
- EBV
- Metabonomics

## Interventions

- **OTHER:** observational

## Key facts

- **NCT ID:** NCT05677178
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677178, "Response Prediction in EBV-HLH Using Metabonomics Analysis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05677178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*